Invasive pneumococcal disease after implementation of a reduced three-dose pneumococcal conjugate vaccine program: a pediatric tertiary care center experience-Reference-Cited by-同舟云学术

Invasive pneumococcal disease after implementation of a reduced three-dose pneumococcal conjugate vaccine program: a pediatric tertiary care center experience

Published:2010-05-22 Issue:11 Volume:169 Page:1311-1315
ISSN:0340-6199
Container-title:European Journal of Pediatrics
language:en
Short-container-title:Eur J Pediatr

Author:

Crisinel Pierre Alex,Chevalier Isabelle,Rallu Fabien,Tapiero Bruce,Lamarre Valérie,Thibault Roseline,Ovetchkine Philippe

Publisher

Springer Science and Business Media LLC

Subject

Pediatrics, Perinatology and Child Health

Link

http://link.springer.com/content/pdf/10.1007/s00431-010-1214-7.pdf

Reference19 articles.

1. 2008. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction—eight states, 1998–2005. Morb Mortal Wkly Rep 57:144–148

2. Bettinger JA, Scheifele DW, Kellner JD et al. (2009) The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000–2007. Vaccine

3. Black S, France EK, Isaacman D et al (2007) Surveillance for invasive pneumococcal disease during 2000–2005 in a population of children who received 7-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 26:771–777

4. Choi EH, Kim SH, Eun BW et al (2008) Streptococcus pneumoniae serotype 19A in children, South Korea. Emerg Infect Dis 14:275–281

5. Dagan R, Givon-Lavi N, Leibovitz E et al (2009) Introduction and proliferation of multidrug-resistant Streptococcus pneumoniae serotype 19A clones that cause acute otitis media in an unvaccinated population. J Infect Dis 199:776–785

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological Targeting of Pore-Forming Toxins as Adjunctive Therapy for Invasive Bacterial Infection;Toxins;2018-12-17

2. Hospitalisation for lower respiratory tract infection in children in the province of Quebec, Canada, before and during the pneumococcal conjugate vaccine era;Epidemiology and Infection;2017-08-14

3. Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: A phase I/II randomized clinical study;Vaccine;2014-11

4. Safety and immunogenicity of an investigational vaccine containing two common pneumococcal proteins in toddlers: A phase II randomized clinical trial;Vaccine;2014-05

5. Effectiveness of the 7-valent pneumococcal conjugate vaccine against vaccine-type invasive disease among children in Uruguay: An evaluation using existing data;Vaccine;2013-07